Effects of glycosaminoglycans on cell proliferation of normal osteoblasts and human osteosarcoma cells depend on their type and fine chemical compositions

Anticancer Research

Volumn 25, Issue 4, 2005, Pages 2851-2856

  Nikitovic, D ^a   Zafiropoulos, A ^a   Tzanakakis, G N ^a   Karamanos, N K ^b   Tsatsakis, A M ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Cell proliferation; Glycosaminoglycans; Osteosarcoma

Indexed keywords

CHONDROITIN SULFATE; DERMATAN SULFATE; DISACCHARIDE; GALACTOSAMINOGLYCAN; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; IDURONIC ACID; PROTEOGLYCAN;

ARTICLE; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MACROMOLECULE; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; SULFATION;

BONE NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CHONDROITIN SULFATES; DERMATAN SULFATE; GLYCOSAMINOGLYCANS; HEPARIN; HUMANS; OSTEOBLASTS; OSTEOSARCOMA;

EID: 22944470086     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Galagher JT: The interaction and regulation of basic and acidic fibroblast growth factors by heparan sulfate. Trends Glycosci Glycotechnol 10: 137-144, 1998.
2. Kjellen L and Lindahl U: Proteoglycans: structures and interactions. Annu Rev Biochem 60: 853-856, 1991.
3. Prydz K and Dalen KT: Synthesis and sorting of proteoglycans. J Cell Science 113: 193-205, 2000.
4. Wight TN, Kinsell MG and Qwarnstroem E: The role of proteoglycans in cell adhesion, migration and proliferation. Curr Opin Cell Biol 4: 793-801, 1992.
5. Tzanakakis GN, Karamanos NK and Hjerpe A: Effects on glycosaminoglycan synthesis in cultured malignant mesothelioma cells of transforming, epidermal and fibroblast growth factors and their combinations with platelet-derived growth factor. Exp Cell Res 220: 130-137, 1995.
6. Wright TC, Castellot JJ, Diamond JR and Karnovsky MJ: Structural determinants of heparin's growth inhibitory activity. Interdependence of oligosaccharide size and charge. J Biol Chem 264: 1534-1542, 1989a.
7. Castellot JJ, Wonk K, Herman B, Hoover RL, Albertini DF and Wright TC: Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol 124: 21-28, 1985.
8. Westergren-Thorsson G, Persson S, Onnervik PO, Malmstrom A and Fransson LA: L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors. Exp Cell Res 206: 93-99, 1993.
9. Takada T, Katagiri T, Ifuku M, Morimura N, Kobayashi M, Hasegawa K, Ogamo A and Kamijo R: Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem 278: 43229-43235, 2003.
10. Volpi N, Bolognani L, Conte A et al: Effects of glycosaminoglycans on U-937 leukaemia cell proliferation and differentiation. Exp Cell Res 215: 119-130, 1994.
11. Volpi N, Bolognani L, Conte A and Petrini M: Effects of chondroitin sulphates with different structures on leukemia cells: U-937 cell proliferation and differentiation. Leukemia Res 17: 789-798, 1993.
12. Syrokou A, Tzanakakis G N, Tsegenidis T, Hjerpe A and Karamanos N: Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure-function relationship. Cell Prolif 32: 85-99, 1999.
13. Beresford JN, Fedarko NS, Fisher LW, Midura RJ, Yanagashita M, Termine JD and Robey PG: Analysis of the proteoglycans synthesized by human bone cells in vitro. J Biol Chem 262: 17164-17172, 1987.
14. Grzesik WJ, Frazier CR, Shapiro JR, Sponseller PD, Gehron Robey P and Fedarko NS: Age-related changes in human bone proteoglycan structure. J Biol Chem 277: 43638-43647, 2002.
15. Benayahu D, Shur I, Marom R, Meller I and Issakov J: Cellular and molecular properties associated with osteosarcoma cells. J Cellular Biochem 84: 108-114, 2001.
16. Nikitovic D, Tsatsakis AM., Karamanos NK and Tzanakakis GN: The effects of genistein on the synthesis and distribution of glycosaminoglycans/ proteoglycans by two osteosarcoma cell lines depends on tyrosine kinase and the estrogen receptor density. Anticancer Res 23: 459-464, 2003.
17. Kletsas D, Basdra EK and Papavassiliou AG: Effect of protein kinase inhibitors on the stretch-elicited c-Fos and c-Jun up-regulation in human PDL osteoblast-like cells. J Cell Physiol 190: 313-321, 2002.
18. Karamanos NK, Hjerpe A, Tsegenidis T, Engfeldt B and Antonopoulos CA: Determination of iduronic acid and glucuronic acid in glycosaminoglycans after stoichiometric reduction and depolarization using high-performance liquid chromatography and ultraviolet detection. Anal Biochem 172: 410-419, 1988.
19. Karamanos NK, Syrokou A, Vanky P, Nurminen M and Hjerpe A: Determination of twenty-four variously sulfated galactosaminoglycans and hyaluronan-derived disaccharides by high performance liquid chromatography. Anal Biochem 221: 189-199, 1994.
20. Karamanos NK, Axelsson S, Vanky P, Tzanakakis GN and Hjerpe A: Determination of hyaluronan and galactosaminoglycan disaccharides by high performance capillary electrophoresis at the attomole level. Applications to analyses of tissue and cell culture proteoglycans. J Chromatogr A 696: 295-305, 1995.
21. Karamanos NK, Vanky P, Tzanakakis GN and Hjerpe A: High-performance capillary electrophoresis method to characterize heparin and heparan sulphate disaccharides. Electrophoresis 17: 391-399, 1996a.
22. Karamanos NK, Vanky P, Tzanakakis GN, Tsegenidis T and Hjerpe A: Ion-pair high-performance liquid chromatography for detecting disaccharide composition in heparin and heparan sulphate. J Chromatogr A 765: 169-179, 1997.
23. Shively JE and Conrad HE: Formation of anhydro-sugars in the chemical depolymerization of heparin. Biochemistry 15: 3932-3942, 1976.
24. Tsuji A, Kinoshita T and Hoshino M: Analytical chemical studies on amino sugars. II. Determination of hexosamines using 3-methyl-2-benzothiazolone hydrazone hydrochloride. Chem Pharm Bull 17: 1505-1510, 1969.
25. Hata R and Nagai T: A rapid and micro method for separation of acidic glycosaminoglycans by two-dimensional electrophoresis. Anal Biochem 45: 462-468, 1972.
26. Engfeldt B, Hjerpe A, Mengarelli S, Reinholdt FP and Wikstrom B: Morphological and biochemical analysis of biopsy specimens in disorders of skeletal development. Acta Paediat Scand 45: 353-363, 1982.
27. Arvaniti A, Karamanos NK, Dimitracopoulos G and Anastassiou ED: Isolation and characterization of a novel 20-kDa sulfated polysaccharide from the extracellular slime layer of Staphylococus epidermidis. Arch Biochem Biophys 308: 432-438, 1994.
28. Kock HJ and Handschin AE: Osteoblast growth inhibition by unfractionated heparin and by low molecular weight heparins: an in vitro investigation. Clin Appl Thromb Hemost 8: 251-255, 2002.
29. Matziolis G, Erli HJ, Rau HM, Klever P, Bosserhoff AK and Paar O: Heparin facilitates proliferation of human osteoblasts in vitro. Orthopade 31: 575-581, 2002.
30. Hausser HJ and Brenner RE: Low doses and high doses of heparin have different effects on osteoblast-like Saos-2 cells in vitro. J Cell Biochem 91: 1062-1073, 2004.
31. Petitou M, Lormeau JC, Choay L and Recherche S: Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs. Nature 350: 30-33, 1991.
32. Nelson-Piercy C: Heparin-induced osteoporosis: Scand J Rheumatol Suppl 107: 68-71, 1998.
33. Lindahl U: 'Heparin' - from anticoagulant drug into the new biology. Glycoconjugate J 17: 597-605, 2000.
34. Rabenstein DL: Heparin and heparan sulfate: structure and function. Nat Prod Rep 19: 312-331, 2002.
35. Lindahl U: What else can "heparin' do? Haemostasis 29(suppl 1): 38-47, 1999.
36. Saksela O, Moscatelli D, Sommer A and Rifkin DB: Endothelial cell-derived heparan sulphate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol 107: 743-751, 1988.